Andrew Xilas - 04 Dec 2023 Form 4 Insider Report for STERIS plc (STE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Dec 2023, 16:35:08 UTC
Prior SEC filing
11 Oct 2023
Next SEC filing
04 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney

Key filing fact

Andrew Xilas filed Form 4 for STERIS plc (STE) on 06 Dec 2023.

Key facts

  • This page summarizes Andrew Xilas's Form 4 filing for STERIS plc (STE).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 06 Dec 2023, 16:35.

Change

  • Previous filing in this sequence was filed on 11 Oct 2023.
  • Current net transaction value: -$19,528.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STE transaction

Ordinary Shares

Options Exercise

Transaction value
$0
Shares
+333
Change %
+5.3%
Price
$0.000000
Shares after
6,569
Date
04 Dec 2023
Ownership
Direct
Footnotes
F1
STE transaction

Ordinary Shares

Tax liability

Transaction value
$19,528
Shares
-98
Change %
-1.5%
Price
$199.27
Shares after
6,471
Date
04 Dec 2023
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STE transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-333
Change %
-100%
Price
$0.000000*
Shares after
0
Date
04 Dec 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
333
Exercise price
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

As of December 4, 2023, 2,912 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 426 on May 31, 2024, 352 on June 3, 2024; 289 on October 1, 2024; 426 on June 2, 2025, 352 on June 2, 2025; 289 on October 1, 2025, 426 on June 1, 2026 and 352 on June 2, 2026.

Footnote F2

Ordinary shares withheld to satisfy taxes.

Footnote F3

All STERIS Restricted Stock Units are fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .